Abpro Holdings (ABPO) Return on Capital Employed (2022 - 2026)
Abpro Holdings' (ABPO) quarterly Return on Capital Employed came in at 124.72% in Q1 2026, up 6548.0% YoY from 1.88% in Q1 2025, and up 17.49% on a QoQ basis from 106.15% in Q4 2025.
Abpro Holdings (ABPO) Return on Capital Employed (2022 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 5 years of Return on Capital Employed data on file, last reported at 124.72% in Q1 2026.
- Quarterly Return on Capital Employed rose 6548.0% year-over-year to 124.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 124.72% (up 6548.0% YoY) and the FY2025 annual result came in at 130.37%, up 6677.0% from the prior year.
- Return on Capital Employed improved to 124.72% in Q1 2026, from 106.15% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 1514.19% in Q3 2024 to a low of 3916.51% in Q2 2024.
- A 5-year average of 68.67% and a median of 58.31% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed sank 391528 bps — and 2025, when it jumped 397389 bps.
- Tracing ABPO's Return on Capital Employed over 5 years: stood at 0.67% in 2022, then sank by 37338 bps to 249.84% in 2023, then soared by 130 bps to 74.33% in 2024, then jumped by 43 bps to 106.15% in 2025, then advanced by 17 bps to 124.72% in 2026.
- The last three Return on Capital Employed figures came in at 124.72% (Q1 2026), 106.15% (Q4 2025), and 63.42% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.76% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.74% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -38.20% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.68% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 26.09% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -6.85% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -50.93% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 7.88% |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | 245.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124.72% |
| Dec 31, 2025 | 106.15% |
| Sep 30, 2025 | 63.42% |
| Jun 30, 2025 | 57.38% |
| Mar 31, 2025 | 59.25% |
| Dec 31, 2024 | 74.33% |
| Sep 30, 2024 | 1,514.19% |
| Jun 30, 2024 | -3,916.51% |
| Mar 31, 2024 | 1,213.78% |
| Dec 31, 2023 | -249.84% |
| Sep 30, 2023 | -5.73% |
| Jun 30, 2023 | -1.23% |
| Mar 31, 2023 | -0.68% |
| Dec 31, 2022 | -0.67% |